Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001104659-25-014407
Filing Date
2025-02-18
Accepted
2025-02-14 21:18:51
Documents
8

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 18571
2 PART II AND III tm2427963d5_partiiandiii.htm PART II AND III 1750862
3 EXHIBIT 4.1 tm2427963d5_ex4-1.htm EX1A-4 SUBS AGMT 82265
4 EXHIBIT 11.1 tm2427963d5_ex11-1.htm EX1A-11 CONSENT 2196
5 GRAPHIC tm2427963d5_partiiandiiiimg1.jpg GRAPHIC 21998
6 GRAPHIC tm2427963d5_partiiandiiiimg2.jpg GRAPHIC 36278
7 GRAPHIC tm2427963d5_partiiandiiiimg3.jpg GRAPHIC 10019
8 GRAPHIC tm2427963d5_ex11-1img001.jpg GRAPHIC 3581
  Complete submission text file 0001104659-25-014407.txt   1954798
Mailing Address 658 W. INDIANTOWN ROAD SUITE 214 JUPTER FL 33458
Business Address 658 W INDIANTOWN RD SUITE 214 JUPITER FL 33458-7535 (561) 575-4451
Cytonics Corp (Filer) CIK: 0001421744 (see all company filings)

EIN.: 208883869 | State of Incorp.: FL
Type: 1-A/A | Act: 33 | File No.: 024-12533 | Film No.: 25632237
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)